D-0799-2016 Class III Terminated
FDA drug recall D-0799-2016 was initiated by Genzyme Corporation on Dec 8, 2015 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is terminated (terminated Aug 1, 2016). Affected quantity: 24 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 6, 2016
- Initiation Date
- Dec 8, 2015
- Termination Date
- Aug 1, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24 vials
Product description
Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by Genzyme Corportation, Cambridge, MA 02142, NDC 58468-0160-1
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution pattern
TN
Code information
Lot # C5370C02; Exp. 02/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0799-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Genzyme Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.